1011507
ClinicalTrials.gov NCT02308111
Research payments
$437,966
Through program year 2020, $437,966 in research payments was reported against 1011507, across 242 payments, paid by Intercept Pharmaceuticals, Inc..
- Paid by
- Intercept Pharmaceuticals, Inc.
- ClinicalTrials.gov
- NCT02308111
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $194,448 | 103 |
| 2019 | Research | $243,519 | 139 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Matthew Cave Louisville, KY Named on 21 payments
- Raj Vuppalanchi Indianapolis, IN Named on 19 payments
- Roberto Firpi- Morell Gainesville, FL Named on 17 payments
- Eric Lawitz San Antonio, TX Named on 16 payments
- Kris Kowdley Seattle, WA Named on 15 payments
- Christopher Bowlus Sacramento, CA Named on 13 payments
- Jonathan Huang Rochester, NY Named on 12 payments
- Chakradhar Reddy Johnson City, TN Named on 10 payments
- Frederic Regenstein Kansas City, MO Named on 9 payments
- James Trotter Dallas, TX Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.